3 news items
$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs
ALPN
VRTX
26 Apr 24
for sustained profitability and continued research investments.
Now, the same research team at Vertex’s San Diego lab is nearing
Wall Street Braces For Another Red Day Ahead Of More Inflation Data While Bitcoin Holds Above $70K: Analyst Sees Any Pullback As 'Phenomenal Buying Opportunity'
ALPN
FAST
HOOD
11 Apr 24
concerns that it may not be on a sustained downward path. This uncertainty led to a significant decline in major indexes at the open. The markets
Reported Earlier, Vertex Advances Inaxaplin Into Phase 3 Portion Of Adaptive Phase 2/3 Clinical Trial For The Treatment Of APOL1-Mediated Kidney Disease
VRTX
1 Apr 24
as a sustained decline of ≥30% from baseline in the eGFR, the onset of end-stage kidney disease or death. The final study analysis will occur when subjects
- Prev
- 1
- Next